U.S., Sept. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07170540) titled 'UNC Cashew Sublingual Immunotherapy' on Sept. 05.
Brief Summary: The CASCADES study will investigate the safety and efficacy of sublingual immunotherapy (SLIT) for the treatment of cashew allergy in children ages 1-11 years old. Primary efficacy will be assessed after 18 months of cashew SLIT. Lab studies and an oral food challenge after 6 months of cashew SLIT will help determine how quickly cashew SLIT begins to take effect.
Study Start Date: Oct., 2025
Study Type: INTERVENTIONAL
Condition:
Cashew Nut Allergy
Tree Nut Allergies
Intervention:
DRUG: Cashew sublingual immunotherapy
Glycerinated cashew extract for use in subli...